Inventor · disambiguated record

Mark J. Macielag

Also filed as: MACIELAG MARK · MACIELAG MARK J · MACIELAG MARK JOSEPH

91 granted patents·25 pending applications·770 citations·filing 1993–2024

99Inventor score

Technology areasA61P C07D A61K C07K C07H

Files withJANSSEN PHARMACEUTICA NV64 ORTHO MCNEIL PHARM INC11 MACIELAG MARK J7 BIAN HAIYAN5 CONNOLLY PETER J5

Top patents by PatentIndex Score

116 records

0198US8426401B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Apr 23, 2013·77 cites·18 claims
0297US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
0397US8759333B2Di-azetidinyl diamide as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 24, 2014·45 cites·2 claims
0497US8741887B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jun 3, 2014·49 cites·4 claims
0597US8697684B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·48 cites·4 claims
0697US8604017B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 10, 2013·49 cites·4 claims
0797US8399454B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Mar 19, 2013·53 cites·17 claims
0896US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
0995US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
1094US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
1194US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
1294US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
1393US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
1493US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
1592US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
1692US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
1791US10968264B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·2 cites·31 claims
1891US10961293B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 30, 2021·2 cites·14 claims
1990US8367653B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Feb 5, 2013·8 cites·19 claims
2090US6492358B2β-carboline derivatives useful as inhibitors of phosphodiesteraseORTHO MCNEIL PHARM INC·Filed 2001·Granted Dec 10, 2002·37 cites·14 claims
2189US6635638B2Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Oct 21, 2003·31 cites·18 claims
2289US2024018208A1Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
2388US8809327B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2012·Granted Aug 19, 2014·13 cites·5 claims
2488US8362000B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·6 cites·17 claims
2588US8153682B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2008·Granted Apr 10, 2012·16 cites·37 claims
2687US8748417B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 10, 2014·9 cites·2 claims
2786US11230526B1Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 25, 2022·2 cites·25 claims
2886US8455476B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Jun 4, 2013·5 cites·30 claims
2986US8415341B2Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitorsCHEVALIER KRISTEN·Filed 2010·Granted Apr 9, 2013·18 cites·18 claims
3086US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
3185US8513423B2Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitorsCONNOLLY PETER J·Filed 2011·Granted Aug 20, 2013·8 cites·16 claims
3285US8362001B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·4 cites·18 claims
3385US6864253B2Benzo[4,5]thieno[2,3-c]pyridine and Benzo[4,5]furo[2,3-c]pyridine Derivatives Useful as Inhibitors of PhosphodiesteraseORTH MCNEIL PHARMACEUTICAL INC·Filed 2002·Granted Mar 8, 2005·20 cites·9 claims
3484US8445477B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 21, 2013·4 cites·20 claims
3584US6765011B27-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormoneORTHO MCNEIL PHARM INC·Filed 2003·Granted Jul 20, 2004·17 cites·14 claims
3683US8450303B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 28, 2013·3 cites·17 claims
3783US6818646B2Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitorsFiled 2003·Granted Nov 16, 2004·19 cites·2 claims
3882US8846655B24-substituted-2-phenoxy-phenylamine delta opioid receptor modulatorsCOATS STEVEN J·Filed 2010·Granted Sep 30, 2014·7 cites·24 claims
3981US8722658B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 13, 2014·2 cites·4 claims
4081US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
4181US8623858B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 7, 2014·2 cites·4 claims
4280US8962607B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·9 claims
4380US8691805B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 8, 2014·2 cites·8 claims
4480US7732612B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Jun 8, 2010·3 cites·12 claims
4580US7179805B27-amino alkylidenyl-heterocyclic quinolones and naphthyridonesJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 20, 2007·15 cites·14 claims
4679US11732019B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
4779US9464055B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·3 cites·16 claims
4878US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
4975US9266835B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·2 cites·21 claims
5074US8378117B2Hexahydro-cycloheptapyrazole cannabinoid modulatorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 19, 2013·2 cites·1 claims

Showing the top 50 of 116 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Mark J. Macielag files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →